Nectar Lifesciences Limited (LUX: NECLF)

Nectar Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	182.4	198.06	175.8	178.08	255.39	212.94
Short-Term Investments	4.95	-	-	-	4.57	1.66
Trading Asset Securities	-	4.95	3.14	4.6	-	-
Cash & Short-Term Investments	187.35	203.01	178.94	182.68	259.96	214.6
Cash Growth	-7.94%	13.45%	-2.05%	-29.73%	21.14%	-1.70%
Accounts Receivable	3,793	3,792	2,796	4,470	3,748	3,959
Other Receivables	75.06	423.11	637.78	670.53	463.64	612.49
Receivables	3,876	4,224	3,438	5,144	4,216	4,576
Inventory	7,494	7,765	7,315	7,213	6,553	10,081
Other Current Assets	1,497	645.76	1,380	1,009	1,359	1,280
Total Current Assets	13,054	12,838	12,312	13,548	12,388	16,152
Property, Plant & Equipment	6,333	6,561	6,904	7,652	8,322	8,607
Long-Term Investments	2.35	2.35	2.35	2.35	2.35	2.35
Other Intangible Assets	507.41	523.93	493.29	430.21	383.64	391.91
Long-Term Accounts Receivable	81.54	81.54	73.46	78.28	102.89	92.29
Long-Term Deferred Tax Assets	24.63	74.78	205.69	28	122.79	-
Other Long-Term Assets	1,829	1,829	1,901	2,169	2,560	1,088
Total Assets	21,832	21,911	21,892	23,908	23,881	26,333
Accounts Payable	4,130	4,197	3,188	3,767	3,422	5,271
Accrued Expenses	31.88	153.5	104.43	510.46	144.13	105.21
Short-Term Debt	-	4,122	4,589	5,028	7,120	6,197
Current Portion of Long-Term Debt	5,296	830.1	684.45	660.81	631.67	375.69
Current Income Taxes Payable	-	-	-	-	-	36.05
Other Current Liabilities	514.39	425.78	343.74	72.85	556.55	493.38
Total Current Liabilities	9,973	9,728	8,909	10,038	11,874	12,479
Long-Term Debt	994.7	1,403	2,265	2,911	1,282	1,215
Long-Term Unearned Revenue	7.33	7.46	7.71	7.96	8.21	8.46
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,165
Other Long-Term Liabilities	-	-0.01	0.01	8.3	18.95	22.87
Total Liabilities	11,054	11,218	11,246	13,029	13,261	14,972
Common Stock	224.26	224.26	224.26	224.26	224.26	224.26
Additional Paid-In Capital	-	3,288	3,288	3,288	3,288	3,288
Retained Earnings	-	7,180	7,134	7,367	7,108	7,849
Shareholders' Equity	10,778	10,692	10,646	10,879	10,620	11,361
Total Liabilities & Equity	21,832	21,911	21,892	23,908	23,881	26,333
Total Debt	6,291	6,355	7,538	8,599	9,034	7,788
Net Cash (Debt)	-6,104	-6,152	-7,359	-8,417	-8,774	-7,573
Net Cash Per Share	-26.78	-27.43	-32.82	-37.53	-39.12	-33.77
Filing Date Shares Outstanding	223.96	224.26	224.26	224.26	224.26	224.26
Total Common Shares Outstanding	223.96	224.26	224.26	224.26	224.26	224.26
Working Capital	3,082	3,110	3,403	3,510	514.36	3,673
Book Value Per Share	48.13	47.68	47.47	48.51	47.36	50.66
Tangible Book Value	10,271	10,169	10,153	10,449	10,237	10,969
Tangible Book Value Per Share	45.86	45.34	45.27	46.59	45.65	48.91
Land	-	192.35	192.35	516.05	806.42	806.42
Buildings	-	1,803	1,760	1,773	1,750	1,650
Machinery	-	10,186	10,011	9,936	9,753	9,513
Construction In Progress	-	657.5	777.83	850.98	986.29	1,150

Source: S&P Capital IQ. Standard template. Financial Sources.